Matches in SemOpenAlex for { <https://semopenalex.org/work/W2996445061> ?p ?o ?g. }
- W2996445061 endingPage "337" @default.
- W2996445061 startingPage "330" @default.
- W2996445061 abstract "Aims The aim of the present study was to investigate the impact of aspirin on prognosis in takotsubo syndrome (TTS). Methods and results Patients from the International Takotsubo (InterTAK) Registry were categorized into two groups based on aspirin prescription at discharge. A comparison of clinical outcomes between groups was performed using an adjusted analysis with propensity score (PS) stratification; results from the unadjusted analysis were also reported to note the effect of the PS adjustment. Major adverse cardiac and cerebrovascular events (MACCE: a composite of death, myocardial infarction, TTS recurrence, stroke or transient ischaemic attack) were assessed at 30-day and 5-year follow-up. A total of 1533 TTS patients with known status regarding aspirin prescription at discharge were included. According to the adjusted analysis based on PS stratification, aspirin was not associated with a lower hazard of MACCE at 30-day [hazard ratio (HR) 1.24, 95% confidence interval (CI) 0.50-3.04, P = 0.64] or 5-year follow-up (HR 1.11, 95% CI 0.78-1.58, P = 0.58). These results were confirmed by sensitivity analyses performed with alternative PS-based methods, i.e. covariate adjustment and inverse probability of treatment weighting. Conclusion In the present study, no association was found between aspirin use in TTS patients and a reduced risk of MACCE at 30-day and 5-year follow-up. These findings should be confirmed in adequately powered randomized controlled trials. ClinicalTrials.gov Identifier: NCT01947621." @default.
- W2996445061 created "2019-12-26" @default.
- W2996445061 creator A5000034477 @default.
- W2996445061 creator A5001666794 @default.
- W2996445061 creator A5002806453 @default.
- W2996445061 creator A5002872853 @default.
- W2996445061 creator A5004104973 @default.
- W2996445061 creator A5004112428 @default.
- W2996445061 creator A5004362368 @default.
- W2996445061 creator A5006800467 @default.
- W2996445061 creator A5006952690 @default.
- W2996445061 creator A5009905903 @default.
- W2996445061 creator A5010017598 @default.
- W2996445061 creator A5011295908 @default.
- W2996445061 creator A5012062131 @default.
- W2996445061 creator A5013727186 @default.
- W2996445061 creator A5014280780 @default.
- W2996445061 creator A5016118935 @default.
- W2996445061 creator A5017226048 @default.
- W2996445061 creator A5017412253 @default.
- W2996445061 creator A5019480519 @default.
- W2996445061 creator A5021903478 @default.
- W2996445061 creator A5023789739 @default.
- W2996445061 creator A5025249336 @default.
- W2996445061 creator A5028085559 @default.
- W2996445061 creator A5028480812 @default.
- W2996445061 creator A5028734833 @default.
- W2996445061 creator A5029245431 @default.
- W2996445061 creator A5031505042 @default.
- W2996445061 creator A5033242180 @default.
- W2996445061 creator A5035254382 @default.
- W2996445061 creator A5035928297 @default.
- W2996445061 creator A5037780761 @default.
- W2996445061 creator A5039058455 @default.
- W2996445061 creator A5039653690 @default.
- W2996445061 creator A5040848081 @default.
- W2996445061 creator A5042163996 @default.
- W2996445061 creator A5042416059 @default.
- W2996445061 creator A5042630628 @default.
- W2996445061 creator A5042969250 @default.
- W2996445061 creator A5043115715 @default.
- W2996445061 creator A5043951848 @default.
- W2996445061 creator A5044118984 @default.
- W2996445061 creator A5044680284 @default.
- W2996445061 creator A5045293936 @default.
- W2996445061 creator A5047217066 @default.
- W2996445061 creator A5047767403 @default.
- W2996445061 creator A5047791204 @default.
- W2996445061 creator A5048631518 @default.
- W2996445061 creator A5049262839 @default.
- W2996445061 creator A5053011724 @default.
- W2996445061 creator A5055182832 @default.
- W2996445061 creator A5055478790 @default.
- W2996445061 creator A5057642620 @default.
- W2996445061 creator A5058517274 @default.
- W2996445061 creator A5059132544 @default.
- W2996445061 creator A5060001036 @default.
- W2996445061 creator A5060452914 @default.
- W2996445061 creator A5061794066 @default.
- W2996445061 creator A5062419379 @default.
- W2996445061 creator A5064148681 @default.
- W2996445061 creator A5064783534 @default.
- W2996445061 creator A5064968157 @default.
- W2996445061 creator A5065852623 @default.
- W2996445061 creator A5066640503 @default.
- W2996445061 creator A5068148673 @default.
- W2996445061 creator A5068746352 @default.
- W2996445061 creator A5073143497 @default.
- W2996445061 creator A5073440750 @default.
- W2996445061 creator A5073675082 @default.
- W2996445061 creator A5075102218 @default.
- W2996445061 creator A5075139311 @default.
- W2996445061 creator A5075513235 @default.
- W2996445061 creator A5076681069 @default.
- W2996445061 creator A5077031288 @default.
- W2996445061 creator A5079070411 @default.
- W2996445061 creator A5079224143 @default.
- W2996445061 creator A5081541213 @default.
- W2996445061 creator A5081546040 @default.
- W2996445061 creator A5082796931 @default.
- W2996445061 creator A5083236244 @default.
- W2996445061 creator A5084825453 @default.
- W2996445061 creator A5086559934 @default.
- W2996445061 creator A5088984122 @default.
- W2996445061 creator A5089159272 @default.
- W2996445061 creator A5089679775 @default.
- W2996445061 creator A5091883415 @default.
- W2996445061 date "2020-02-01" @default.
- W2996445061 modified "2023-10-16" @default.
- W2996445061 title "Impact of aspirin on takotsubo syndrome: a propensity score‐based analysis of the InterTAK Registry" @default.
- W2996445061 cites W1183879970 @default.
- W2996445061 cites W1761464837 @default.
- W2996445061 cites W1965475935 @default.
- W2996445061 cites W1967385111 @default.
- W2996445061 cites W1976789927 @default.
- W2996445061 cites W2011456940 @default.
- W2996445061 cites W2018839159 @default.
- W2996445061 cites W2024960324 @default.